NCT03203187

Brief Summary

In the current proposal the investigators seek to evaluate the acute and short-term effects of mango intake on vascular and platelet function in postmenopausal women between 50 and 70 years old. Our aims are 1) to determine if two weeks of daily mango intake will result in favorable changes in measures of vascular function, as measured using peripheral arterial tonometry (PAT) and platelet reactivity, in overweight and obese postmenopausal women. 2) to determine if two weeks of daily mango intake will change the fermentation capacity of gut microbiota. Investigators hypothesize that the daily intake of 330 grams of mango (2 cups) will significantly increase PAT while reducing platelet aggregation after 2 hours and two weeks of daily intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2020

Completed
Last Updated

September 2, 2022

Status Verified

September 1, 2022

Enrollment Period

4 years

First QC Date

February 27, 2017

Last Update Submit

September 1, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Acute vascular function

    Comparison of the effect of mango on acute vascular function between baseline and 2-hour postprandial response using PAT.

    change from baseline to 2 hours compared on days 0 14 and 28

  • Long-term vascular function

    The effect of mango on long-term vascular function between baseline, two week, and four week time points using PAT

    Comparison of day 0, 14, and 28

Secondary Outcomes (2)

  • Acute platelet aggregation

    change from baseline to 2 hours compared on days 0 14 and 28

  • Long-term platelet aggregation

    Comparison of day 0, 14, and 28

Study Arms (2)

No mango intake

PLACEBO COMPARATOR

No mango intake for two weeks

Other: No intervention

330 grams of daily mango intake

EXPERIMENTAL

330 grams (2 cups) of daily mango intake for two weeks

Other: Mango

Interventions

MangoOTHER

330 grams (2 cups) of daily mango intake for two weeks, one cup in the morning, the other in the evening

330 grams of daily mango intake

No mango intake for two weeks.

No mango intake

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal female: 50-70 years
  • Women: lack of menses for at least one year and FSH 23-116.3 mlU/mL
  • Subject is willing and able to comply with the study protocols.
  • Subject is willing participate in all study procedures
  • BMI 25.0 - 40 kg/m2
  • Weight ≥ 110 pounds

You may not qualify if:

  • BMI ≥ 40 kg/m2
  • Dislike or allergy for mango
  • Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
  • Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
  • Alcohol consumption \> 3 drinks/week (i.e. 1 bottle of beer, ½ glass of wine, and 1 shot of hard liquor)
  • Fruit consumption ≥ 2 cups/day
  • Vegetable consumption ≥ 3 cups/day for females
  • Fatty Fish ≥ 3 times/week
  • Coffee/tea ≥ 3 cups/day
  • Dark chocolate ≥ 3 oz/day
  • Self-reported restriction of physical activity due to a chronic health condition
  • Self-reported chronic/routine high intensity exercise
  • Self-reported diabetes
  • Blood pressure ≥ 140/90 mm Hg
  • Self-reported renal or liver disease
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regal Human Nutrition Research Center

Davis, California, 95616, United States

Location

MeSH Terms

Interventions

Mangifera indica extract

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2017

First Posted

June 29, 2017

Study Start

October 2, 2016

Primary Completion

September 14, 2020

Study Completion

September 14, 2020

Last Updated

September 2, 2022

Record last verified: 2022-09

Locations